This narrative state-of-the-art review paper describes the progress in the understanding and
treatment of Posttraumatic Stress Disorder (PTSD). Over the last four decades, the scientific …

The aim of this review was to determine the effect of psilocybin on depressive symptoms in
patients diagnosed with life-threatening illnesses or major depressive disorder. Systematic …

The psychedelic 5-HT 2A receptor (5HT2AR) agonist psilocybin (or the active metabolite
psilocin) has emerged as potential useful drug for various neuropsychiatric diseases, with a …

Objective Serotonergic psychedelics are re-emerging as potential novel treatments for
several psychiatric disorders including major depressive disorder. The Canadian Network …

The word “psychedelic”(psyche (ie, the mind or soul) and delos (ie, to show)) has Greek
origin and was first coined by psychiatrist Humphry Osmond in 1956, who had been …

Hallucinogenic mushrooms have been used in religious and cultural ceremonies for
centuries. Of late, psilocybin, the psychoactive compound in hallucinogenic mushrooms, has …

Background: Research on psilocybin has become increasingly popular during the current
psychedelic renaissance, which began in the early 1990s. Psilocybin's effects on mental …

The need to identify effective therapies for the treatment of psychiatric disorders is a
particularly important issue in modern societies. In addition, difficulties in finding new drugs …

The Western world is experiencing a resurgence of interest in the therapeutic potential of
psychedelics, most of which are derived from plants or fungi with a history of Indigenous …

Therapeutic use of psilocybin has become a focus of recent international research, with
preliminary data showing promise to address a range of treatment-resistant mental health …